Compositions of phosphorylated tau peptides and uses thereof
US11124552B2 · kind B2 · utility
5Cited by
2References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 24, 2018 |
| Grant date | Sep 21, 2021 |
| Priority date | — |
| Expiry date | Oct 24, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/627
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Liposomes containing tau peptides, preferably phosphorylated tau peptides, and conjugates containing tau peptides, preferably phosphorylated tau peptides, conjugated to an immunogenic carrier are described. Pharmaceutical compositions and uses of the liposomes and/or conjugates for treating or preventing a neurodegenerative disease or disorder, such as Alzheimer's Disease, are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.